AKRO
Akero Therapeutics Inc.
Company Overview
| Mkt Cap | $3.69B | Price | $54.20 |
| Volume | 1.14M | Change | -0.11% |
| P/E Ratio | -14.6 | Open | $54.25 |
| Revenue | -- | Prev Close | $54.26 |
| Net Income | $-252.1M | 52W Range | $21.34 - $58.40 |
| Div Yield | N/A | Target | $67.44 |
| Overall | 59 | Value | 60 |
| Quality | 42 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyAkero Therapeutics Inc. (AKRO) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $54.20 with a market capitalization of $3.69 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows AKRO with a volume of 1.14 million shares. The stock opened down 0.02% from yesterday's close of $54.26. Current analyst estimates project earnings of $-3.76 per share for this year, with next year targeting $-4.16.
AKRO demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for AKRO include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 24.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 11:46 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKRO | $54.20 | -0.1% | 1.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |